In the 1960s, the recreational overuse of psychedelics led them to be classified as a Schedule 1 drug, making it impossible to conduct further clinical research. Due to the opioid epidemic, and the known analgesic effects of psychedelics, their potential use to treat chronic pain is being revisited in clinical trials.
The Lumina Medical Academy houses a variety of full and shorter courses designed to aid the continuous professional development of healthcare providers in the field of pain management. Content on the Academy is co-created by a collaborative of independent and internationally recognized experts and specialists and has been developed in such a way that they can be done at one's own pace.
